The Early Retirees

The University has disclosed information on the staff members, by school, who were offered and who accepted its voluntary early-retirement incentive program.

The University has disclosed how many staff members, by school, were offered and accepted the voluntary early-retirement incentive--for those 55 years and older, with 10 or more years of Harvard service--one of the principal cost-saving measures implemented so far. (For background, see here ). The offers were made in two waves, concluded in early May. In all, 531 of 1,628 eligible employees--32.6 percent-accepted.

This exhibit, with data from Harvard Human Resources, was published in the June 2009 issue of the Harvard Resource, the employee newspaper.

 

You might also like

A History of Harvard Magazine

Harvard’s independent alumni magazine—at 127 years old 

Creepy Crawlies and Sticky Murder Weapons at Harvard

In the shadows of Singapore’s forests, an ancient predator lies in wait—the velvet worm.

Harvard’s Endowment, Donations Rise—but the University Runs a Deficit

The annual financial report signals severe challenges to come.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard Announces Four University Professors

Catherine Dulac, Noah Feldman, Claudia Goldin, and Cumrun Vafa receive the University’s highest faculty distinction.

Explore More From Current Issue

A vibrant bar scene with tropical decor, featuring patrons sitting on high stools.

Best Bars for Seasonal Drinks and Snacks in Greater Boston

Gathering spots that warm and delight us  

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.